• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Promimic

10.30 SEK

0.00 %

Less than 1K followers

PRO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-8.04 %
-5.94 %
-39.23 %
-28.97 %
-43.09 %
-60.38 %
-
-36.74 %

Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.

Read more
Market cap
194.59M SEK
Turnover
1.13K SEK
Revenue
44.42M
EBIT %
-17.33 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
20/8
2026

Interim report Q2'26

19/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-05-21 18:00

Kommuniké från årsstämma 2026 i Promimic AB (publ)

Promimic
Regulatory press release2026-05-19 07:30

Promimic AB: Positivt kassaflöde och tillväxt i kärnaffären i det första kvartalet 2026

Promimic
Regulatory press release2026-04-16 07:30

Kallelse till årsstämma i Promimic AB (publ)

Promimic

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-04-15 14:00

Promimic AB: Promimic anlitar ABG Sundal Collier som likviditetsgarant

Promimic
Regulatory press release2026-04-10 13:15

Promimic AB: Promimic Årsredovisning för 2025

Promimic
Regulatory press release2026-02-24 07:30

Promimic AB: Promimic Bokslutskommuniké 2025 och Kvartal 4: Investeringar för tillväxt

Promimic
Regulatory press release2025-11-19 07:30

Promimic AB: Bästa kvartalet hittills i Q3 2025

Promimic
Regulatory press release2025-10-14 16:00

Valberedning utsedd i Promimic AB (publ)

Promimic
Press release2025-09-22 14:38

Analyst Group: Analyst Group intervjuar Promimics VD Magnus Larsson

Promimic
Regulatory press release2025-08-22 07:30

Promimic AB: Kvartal 2 Rekordmånga nya kundavtal

Promimic
Regulatory press release2025-08-15 12:00

Promimic AB byter Certified Adviser till Tapper Partners AB

Promimic
Regulatory press release2025-05-22 16:00

Kommuniké från årsstämma 2025 i Promimic AB (publ)

Promimic
Regulatory press release2025-05-15 07:30

Promimic AB: Strategiska affärer för tillväxt i Kvartal 1 2025

Promimic
Press release2025-05-05 16:00

Promimic AB: Fördjupat samarbete med Curiteva

Promimic
Press release2025-04-23 09:00

Promimic AB: Strategiskt samarbetsavtal med Lincotek

Promimic
Regulatory press release2025-04-17 07:30

Kallelse till årsstämma i Promimic AB (publ)

Promimic
Regulatory press release2025-04-10 08:00

Promimic AB: Promimic Årsredovisning 2024

Promimic
Regulatory press release2025-03-03 11:15

VD:n säljer del av sitt aktieinnehav i Promimic AB (publ)

Promimic
Regulatory press release2025-02-25 07:30

Promimic AB: Promimic Bokslutskommuniké 2024 och Kvartal 4: All-Time-High

Promimic
Press release2025-02-17 16:00

Promimic AB: Nya resultat visar att beläggning av implantat med HA[nano] Surface minskar förekomsten av bakterier

Promimic